Publications by authors named "Kodys K"

Acute liver injury (ALI) is associated with multiple cellular events such as necrosis, apoptosis, oxidative stress and inflammation, which can lead to liver failure. In this study, we demonstrate a new role of microRNA (miR)-208a in ALI. ALI was induced in wild-type (WT) and miR-208a knockout (KO) mice by CCl administration.

View Article and Find Full Text PDF

Cellular homeostais, that is normally maintained through autophagy, is disrupted in alcoholic liver disease (ALD). Because autophagy and exosome biogenesis share common elements, we hypothesized that increased exosome production in ALD may be linked to disruption of autophagic function. We found impaired autophagy both in ALD and alcoholic hepatitis (AH) mouse models and human livers with ALD as indicated by increased hepatic p62 and LC3-II levels.

View Article and Find Full Text PDF

Although mortality due to acute alcoholic hepatitis (AH) correlates with Model for End-Stage Liver Disease (MELD) scores, biomarkers are critically needed to manage this disease. Increases in inflammatory markers and macrophage activation are associated with acute AH and could be potential biomarkers of clinical events and/or mortality. We enrolled 89 clinically diagnosed AH patients in four US academic medical centers.

View Article and Find Full Text PDF

Bile acids (BAs) activate various dedicated receptors, including the farnesoid X receptor (FXR) and the Takeda G protein-coupled receptor 5 (TGR5). The FXR agonist obeticholic acid (OCA) is licensed for the treatment of primary biliary cholangitis and has shown promising results in NASH patients, whereas TGR5 agonists target inflammation and metabolism. We hypothesized that FXR and/or TGR5 agonists may be therapeutic in early alcoholic liver disease (ALD) in mice, in which hepatic inflammation plays a major role.

View Article and Find Full Text PDF
Article Synopsis
  • Kupffer cells and macrophage activation contribute to liver issues in alcoholic liver disease (ALD), leading to fat buildup, inflammation, and fibrosis, with increased MØ and T cells observed in patients.* -
  • The study tested the dual CCR2/5 inhibitor, cenicriviroc (CVC), in a mouse model and found it effectively reduced liver injury and fat buildup related to alcohol consumption, whether given preventively or as treatment.* -
  • CVC also normalized markers of liver fibrosis and inflammation, increased T-cell numbers, and prevented harmful effects on liver cells, suggesting it may be a potential treatment for ALD.*
View Article and Find Full Text PDF

Inflammatory cell activation drives diverse cellular programming during hepatic diseases. Hypoxia-inducible factors (HIFs) have recently been identified as important regulators of immunity and inflammation. In nonalcoholic steatohepatitis (NASH), HIF-1α is upregulated in hepatocytes, where it induces steatosis; however, the role of HIF-1α in macrophages under metabolic stress has not been explored.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how binge drinking affects neutrophils, particularly their ability to form NETs (neutrophil extracellular traps) and undergo NETosis, in the context of acute sepsis.
  • It was found that binge drinking leads to increased levels of NET in the bloodstream, but initially reduces NET formation when the body encounters bacteria (LPS).
  • Alcohol also negatively impacts the clearance of NETs by macrophages, which could exacerbate inflammation and liver injury after sepsis.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how extracellular vesicles (EVs) from mice with alcoholic liver disease (ALD) affect immune cell activation and inflammation, revealing that these EVs have a unique protein profile linked to the disease.
  • Researchers found that ALD EVs increased the number and activation of inflammatory macrophages and Kupffer cells in recipient mice, while decreasing anti-inflammatory macrophages.
  • The study identifies heat shock protein 90 as a key protein in ALD EVs that drives macrophage activation and inflammatory response, indicating its potential role in the progression of alcoholic liver disease.
View Article and Find Full Text PDF

Background & Aims: Chronic, excessive alcohol consumption leads to alcoholic liver disease (ALD) characterized by steatosis, inflammation, and eventually cirrhosis. The hepatocyte specific microRNA 122 (MIR122) regulates hepatocyte differentiation and metabolism. We investigated whether an alcohol-induced decrease in level of MIR122 contributes to development of ALD.

View Article and Find Full Text PDF

Inflammation promotes the progression of alcoholic liver disease. Alcohol sensitizes KCs to gut-derived endotoxin (LPS); however, signaling pathways that perpetuate inflammation in alcoholic liver disease are only partially understood. We found that chronic alcohol feeding in mice induced miR-155, an inflammatory miRNA in isolated KCs.

View Article and Find Full Text PDF
Article Synopsis
  • Alcohol consumption disrupts gut microbiome balance, which is linked to the development of alcoholic liver disease by affecting the gut-liver axis.
  • In an experiment with mice, alcohol diet led to increased certain bacteria and decreased others, showing how diet affects gut health and liver inflammation markers.
  • Treating mice with antibiotics reduced harmful bacteria and inflammation but did not prevent increases in liver enzymes related to liver damage from alcohol.
View Article and Find Full Text PDF

Background & Aims: Inflammation and impaired hepatocyte regeneration contribute to liver failure in alcoholic hepatitis (AH). Interleukin (IL)-1 is a key inflammatory cytokine in the pathobiology of AH. The role of IL-1 in liver regeneration in the recovery phase of alcohol-induced liver injury is unknown.

View Article and Find Full Text PDF

Monocytes and macrophages (MΦs) play a central role in the pathogenesis of chronic hepatitis C virus (HCV) infection. The tissue microenvironment triggers monocyte differentiation into MΦs, with polarization ranging within the spectrum of M1 (classical) to M2 (alternative) activation. Recently, we demonstrated that HCV infection leads to monocyte differentiation into polarized MΦs that mediate stellate cell activation via TGF-β.

View Article and Find Full Text PDF

Background & Aims: Monocyte and macrophage (MΦ) activation contributes to the pathogenesis of chronic hepatitis C virus (HCV) infection. Disease pathogenesis is regulated by both liver-resident MΦs and monocytes recruited as precursors of MΦs into the damaged liver. Monocytes differentiate into M1 (classic/proinflammatory) or M2 (alternative/anti-inflammatory) polarized MΦs in response to tissue microenvironment.

View Article and Find Full Text PDF
Article Synopsis
  • Obesity and related inflammation can stimulate cancer development, particularly in liver cancer (HCC), by affecting how immune cells called macrophages behave in the tumor environment.
  • * A study using male mice revealed that a western diet led to non-alcoholic steatohepatitis (NASH) and increased the presence of M2 macrophages, which support tumor growth and invasiveness.
  • * The study found that the hypoxia-inducible factor (hif-1α) was crucial in promoting M2 macrophage polarization through the cytokine IL-10, suggesting that targeting this pathway could be a potential strategy for slowing HCC progression in the context of obesity-related NASH.
View Article and Find Full Text PDF
Article Synopsis
  • Fibrosis in chronic liver diseases is linked to inflammation, but the role of hepatocyte death in its development is unclear.
  • The research hypothesizes that hepatocyte death, regulated by IRF3 and STING signaling, is a critical factor in chemically induced liver fibrogenesis.
  • Findings show that IRF3 and STING deficiency prevent hepatocyte death and fibrosis, suggesting that IRF3's apoptotic function is independent of TLR signaling in the progression of liver fibrosis.
View Article and Find Full Text PDF

Unlabelled: The spectrum of alcoholic liver disease (ALD) is a major cause of mortality with limited therapies available. Because alcohol targets numerous signaling pathways in hepatocytes and in immune cells, the identification of a master regulatory target that modulates multiple signaling processes is attractive. In this report, we assessed the role of spleen tyrosine kinase (SYK), a nonreceptor tyrosine kinase, which has a central modulatory role in multiple proinflammatory signaling pathways involved in the pathomechanism of ALD.

View Article and Find Full Text PDF

Background: Binge drinking is increasingly recognized as an important cause of liver disease with limited therapeutic options for patients. Binge alcohol use, similar to chronic alcohol consumption, induces numerous deregulated signaling events that drive liver damage, steatosis, and inflammation. In this article, we evaluated the role of spleen tyrosine kinase (SYK), which modulates numerous signaling events previously identified linked in the development alcohol-induced liver pathology.

View Article and Find Full Text PDF

Background & Aims: Alcoholic liver disease (ALD) ranges from fatty liver to inflammation and cirrhosis. miRNA-155 is an important regulator of inflammation. In this study, we describe the in vivo role of miR-155 in ALD.

View Article and Find Full Text PDF
Article Synopsis
  • Membrane-coated extracellular vesicles (EVs) can carry biological signals, and alcohol-treated monocytes release more exosomes that influence naive monocytes.
  • Alcohol increases the production of these EVs, leading naive monocytes to polarize into M2 macrophages, which are associated with anti-inflammatory responses.
  • The key component driving this polarization is miR-27a, which is found in higher levels in EVs from alcohol-exposed monocytes and is linked to increased phagocytic activity and specific surface markers.
View Article and Find Full Text PDF
Article Synopsis
  • Alcohol consumption leads to liver injury and inflammation, but there are currently no reliable biomarkers to gauge the severity of alcoholic hepatitis (AH).
  • Researchers hypothesized that miRNAs associated with exosomes could serve as potential biomarkers for monitoring liver injury in AH patients.
  • Their study found that the number of circulating exosomes increased in alcohol-fed mice, identifying specific inflammatory miRNAs that could effectively distinguish alcohol-induced liver damage in both mouse and human samples.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how metabolic danger signals, specifically uric acid and ATP, activate the inflammasome in the context of alcoholic steatohepatitis (ASH), a liver condition caused by excessive alcohol consumption.
  • Researchers conducted experiments on various mouse models to observe the effects of these signals and tested pharmacological treatments to mitigate their impact on inflammation and liver damage.
  • Findings suggest that the presence of uric acid and ATP in alcohol-fed mice contributes to inflammasome activation and IL-1β production, indicating potential therapeutic strategies to target these signals in treating ASH.
View Article and Find Full Text PDF
Article Synopsis
  • Non-alcoholic fatty liver disease (NAFLD) is a growing health issue, and this study aims to develop a mouse model that accurately represents its progression to more serious conditions like non-alcoholic steatohepatitis (NASH) and liver cancer.
  • The research involved feeding male C57Bl/6 mice a high-fat, high-cholesterol, and high-sugar diet, with evaluations at 8, 27, and 49 weeks to assess liver damage, inflammation, and tumor development.
  • Findings revealed that liver steatosis developed within 8 weeks, progressing to more severe conditions and tumor formation by 49 weeks, with molecular signals indicating inflammation and the activation of specific immune responses that mirror
View Article and Find Full Text PDF

Background & Aim: MicroRNAs (miRs) regulate hepatic steatosis, inflammation and fibrosis. Fibrosis is the consequence of chronic tissue damage and inflammation. We hypothesized that deficiency of miR-155, a master regulator of inflammation, attenuates steatohepatitis and fibrosis.

View Article and Find Full Text PDF